share_log

Capricor Therapeutics shares are trading higher after the company announced it signed an exclusive, worldwide licensing agreement with Johns Hopkins University to expand its exosome platform technolog

Capricor Therapeutics shares are trading higher after the company announced it signed an exclusive, worldwide licensing agreement with Johns Hopkins University to expand its exosome platform technolog

Capricor Treateutics股價上漲,此前該公司宣佈與約翰·霍普金斯大學(Johns Hopkins University)簽署了一項獨家的全球許可協議,以擴大其外體平台Technolog
Benzinga ·  2021/04/29 09:35

Capricor Therapeutics shares are trading higher after the company announced it signed an exclusive, worldwide licensing agreement with Johns Hopkins University to expand its exosome platform technology portfolio.

Capricor Treateutics的股價上漲,此前該公司宣佈與約翰·霍普金斯大學(Johns Hopkins University)簽署了一項獨家的全球許可協議,以擴大其Exosome平台技術組合。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論